Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bright light does not alter muscarinic receptor binding parameters.

M L Giroux1, E Malatynska, S C Dilsaver

  • 1Medical Scientist Training Program, Ohio State University, College of Medicine.

Pharmacology, Biochemistry, and Behavior
|March 1, 1991
PubMed
Summary

Bright light therapy for Seasonal Affective Disorders (SADs) did not alter muscarinic receptor density in the brain. This finding offers new insights into the biological mechanisms underlying winter depression and its treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The interaction of a benzodiazepine receptor antagonist (Ro15-1788) with GABA and GABA receptor antagonists at the GABA(A) receptor chloride-ionophore complex.

Neurochemistry international·2010
Same author

Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.

Neurology·2006
Same author

BDNF genetic variants are associated with onset age of familial Parkinson disease: GenePD Study.

Neurology·2005
Same author

Different levels of gamma-synuclein mRNA in the cerebral cortex of dominant, neutral and submissive rats selected in the competition test.

Genes, brain, and behavior·2005
Same author

Central GABAergic systems and depressive illness.

Neurochemical research·2003
Same author

Structure of mania: depressive, irritable, and psychotic clusters with different retrospectively-assessed course patterns of illness in randomized clinical trial participants.

Journal of affective disorders·2002

Area of Science:

  • Neuroscience
  • Psychiatry
  • Chronobiology

Background:

  • Seasonal Affective Disorders (SADs) involve mood episodes linked to seasons, with winter depression being a common form.
  • Winter depression typically resolves spontaneously in spring and responds to bright light therapy.
  • Central muscarinic mechanisms are hypothesized to play a role in the pathophysiology of depressive disorders.

Purpose of the Study:

  • To investigate the effect of bright light treatment on muscarinic receptor density in patients with Seasonal Affective Disorders.
  • To explore the potential involvement of central muscarinic mechanisms in the therapeutic action of light therapy for winter depression.

Main Methods:

  • Physiological studies were conducted to assess muscarinic receptor density.
  • Measurements were taken in specific brain regions, including the hypothalamus and striatum.

Related Experiment Videos

  • The impact of bright light treatment on receptor density was evaluated.

    • Main Results:

    • Contrary to expectations, bright light treatment did not lead to a decrease in muscarinic receptor density.
    • No significant changes in muscarinic receptor density were observed in either the hypothalamus or the striatum following light therapy.

    Conclusions:

    • The findings suggest that the therapeutic effects of bright light for winter depression may not be mediated by alterations in central muscarinic receptor density.
    • Further research is needed to elucidate the precise neurobiological pathways involved in Seasonal Affective Disorders and their response to light therapy.